Pakistani Researchers Pioneer Innovative Nasal Spray for Epilepsy and Stroke Treatment
Researchers from the University of Karachi’s H.E.J. Research Institute of Chemistry have unveiled a promising new drug candidate, known as Z-acid, which could revolutionize how we manage epilepsy and stroke. Unveiled at Dubai Future Week 2026, this neuroprotective compound is derived from a traditional medicinal plant. By utilizing a nasal spray delivery system, the team discovered they could achieve better results than traditional injections in animal studies. This is a critical advancement, as roughly 30% of epilepsy patients currently struggle with drug-resistant seizures, and existing emergency treatments like FDA-approved nasal sprays remain prohibitively expensive for many.
The development process involved isolating active compounds from plants historically used for neurological ailments, ensuring the treatment functions similarly to established medications but with a superior safety profile. Notably, Z-acid has shown no signs of DNA damage, reproductive harm, or negative impacts on red blood cells during preclinical trials. Furthermore, the compound appears to promote neurogenesis, which assists the brain in repairing itself after a stroke, with test subjects showing symptom resolution within just one week. While the drug is currently in the prototype stage and awaits regulatory approval for human clinical trials in Pakistan, its patented status and versatility suggest a hopeful future for treating a wide array of central nervous system disorders.